Preoperative radiotherapy has no value for patients with T2-3, n0 adenocarcinomas of the rectum

Digestive Surgery

Volumn 26, Issue 4, 2009, Pages 291-296

  Ferenschild, Floris T J ^a   Dawson, Imro ^a   De Graaf, Eelco J R ^a   De Wilt, Johannes H W ^b   Tetteroo, Geert W M ^a  

^a IJSSELLAND HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adjuvant treatment; Carcinoma; Local recurrence; Neoadjuvant treatment; Radiotherapy; Rectal cancer; Total mesorectal excision

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; AGING; ARTICLE; BONE METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE CARE; PROTEIN BLOOD LEVEL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; SURGICAL TECHNIQUE; TOTAL MESORECTAL EXCISION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 67649867892     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227771     Document Type: Article

References (31)

1. Wiggers T, de Vries MR, Veeze-Kuypers B: Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996; 39: 323-328.
2. Van Den Brink M, Stiggelbout AM, Van Den Hout WB, et al: Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004; 22: 3958-3964.
3. Vermaas M, Ferenschild FT, Nuyttens JJ, et al: Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 2005; 48: 918-928.
4. Kapiteijn E, Marijnen CA, Colenbrander AC, et al: Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol 1998; 24: 528-535.
5. Heald RJ, Husband EM, Ryall RD: The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982; 69: 613-616.
6. Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482.
7. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646. (Pubitemid 34936565)
8. Peeters KC, Marijnen CA, Nagtegaal ID, et al: The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
9. Simunovic M, Sexton R, Rempel E, Moran BJ, Heald RJ: Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg 2003; 90: 999-1003.
10. Nissan A, Stojadinovic A, Shia J, et al: Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 2006; 24: 4078-4084.
11. Quirke P, Durdey P, Dixon MF, Williams NS: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-999.
12. Goldberg S, Klas JV: Total mesorectal excision in the treatment of rectal cancer: a view from the USA. Semin Surg Oncol 1998; 15: 87-90.
13. MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460.
14. Kapiteijn E, Kranenbarg EK, Steup WH, et al: Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg 1999; 165: 410-420.
15. Vermaas M, Gosselink MP, Ferenschild FT, et al: Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Eur J Surg Oncol 2007; 33: 862-867.
16. Jestin P, Pahlman L, Gunnarsson U: Risk factors for anastomotic leakage after rectal cancer surgery: a case-control study. Colorectal Dis 2008; 10: 715-721.
17. Lange MM, Van De Velde CJ: Faecal and urinary incontinence after multimodality treatment of rectal cancer. PLoS Med 2008; 5: e202.
18. Lange MM, Marijnen CA, Maas CP, et al: Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 2009; 45: 1578-1588.
19. Balch GC, De Meo A, Guillem JG: Modern management of rectal cancer: a 2006 update. World J Gastroenterol 2006; 12: 3186-3195.
20. Tzardi M: Role of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma. Dig Dis 2007; 25: 51-55.
21. Law WL, Chu KW: Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 2004; 240: 260-268.
22. den Dulk M, Collette L, van de Velde CJ, et al: Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. Eur J Cancer 2007; 43: 1821-1828.
23. Huh JW, Jung EJ, Park YA, Lee KY, Sohn SK: Sphincter-preserving operations following preoperative chemoradiation: an alternative to abdominoperineal resection for lower rectal cancer? World J Surg 2008; 32: 1116-1123.
24. Debes AJ, Storkson RH, Jacobsen MB: Curative rectal cancer surgery in a low-volume hospital: a quality assessment. Eur J Surg Oncol 2008; 34: 382-389.
25. Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer Van Driel OJ, Coebergh JW: Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005; 92: 615-623.
26. Rutten HJ, Den Dulk M, Lemmens VE, Van De Velde CJ, Marijnen CA: Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 2008; 9: 494-501.
27. Endreseth BH, Romundstad P, Myrvold HE, Bjerkeset T, Wibe A: Rectal cancer treatment of the elderly. Colorectal Dis 2006; 8: 471-479.
28. Law WL, Choi HK, Ho JW, Lee YM, Seto CL: Outcomes of surgery for mid and distal rectal cancer in the elderly. World J Surg 2006; 30: 598-604.
29. Larsen SG, Wiig JN, Tretli S, Giercksky KE: Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis 2006; 8: 177-185.
30. Guillem JG, Diaz-Gonzalez JA, Minsky BD, et al: cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 2008; 26: 368-373.
31. Leibold T, Shia J, Ruo L, et al: Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol 2008; 26: 2106-2111.